Nat Commun:脑部特异性抑制mTORC1帮助治疗酒精成瘾

2021-07-28 haibei MedSci原创

在临床上使用的mTORC1抑制剂是治疗AUD有希望的治疗药物。然而,长期抑制外周组织的mTORC1会产生不良的副作用,这限制了它们在治疗AUD方面的潜在用途。

酒精使用障碍(AUD)的特点是不顾不良后果,强迫性地摄入酒精。AUD的存在很普遍,影响10-15%的人口,可以造成重大的医疗、社会和经济负担。事实上,AUD是最普遍的精神健康疾病之一,2001年至2013年期间,美国AUD的诊断发生率增加了35%。

不幸的是,针对AUD的药物治疗选择有限。目前只有三种药物,纳曲酮、阿坎酸和双硫仑,被美国食品和药物管理局(FDA)批准为治疗AUD的药物。因此,我们有必要开发更多的有效药物,以缓解酗酒、成瘾和复发等表型。

对啮齿类动物的研究表明,mTORC1在重度酒精摄入、成瘾和复发等表型背后的机制中起着关键作用。已知mTORC1是一个多蛋白复合物,包含丝氨酸/苏氨酸蛋白激酶mTOR以及适应蛋白(包括Raptor、Deptor和mLST8)。mTORC1被生长因子、氨基酸和氧气激活,并在脂质生成、葡萄糖平衡、蛋白质翻译和自噬中发挥作用。

已有的研究显示,mTORC1的过度激活与多种病理状态有关,如胰岛素抵抗和癌症。在中枢神经系统(CNS),mTORC1可以被神经递质和神经调节剂激活,如谷氨酸和BDNF。

在临床上使用的mTORC1抑制剂是治疗AUD有希望的治疗药物。然而,长期抑制外周组织的mTORC1会产生不良的副作用,这限制了它们在治疗AUD方面的潜在用途。

为了克服这些限制,最近,研究人员设计了一种二元药物策略,即用mTORC1抑制剂RapaLink-1和一种小分子(RapaBlock)一起治疗雄性小鼠,以保护外周组织中的mTORC1活性

策略的示意图

该研究结果表明,虽然RapaLink-1的给药阻断了肝脏中mTORC1的激活,但RapaBlock消除了Rapalink-1的抑制作用。RapaBlock还可以防止长期抑制mTORC1所产生的不良副作用

RapaBlock有效预防了RapaLink-1依赖性的体重减轻、葡萄糖不耐受和肝脏毒性

重要的是,RapaLink-1和RapaBlock的共同给药抑制了酒精依赖性mTORC1在横状隔核中的激活,并削弱了对酒精的需求和饮用

 

原始出处:

Yann Ehinger et al. Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice. Nature Communications (2021). 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2086150, encodeId=b88920861503d, content=<a href='/topic/show?id=82ed9548916' target=_blank style='color:#2F92EE;'>#酒精成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95489, encryptionId=82ed9548916, topicName=酒精成瘾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Wed Jun 08 22:09:50 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885334, encodeId=9c9c18853343b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 02 04:09:50 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088076, encodeId=d17320880e678, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Aug 05 09:09:50 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081430, encodeId=bf321081430cb, content=aws的情况确实要多关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Sat Dec 18 07:25:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899506, encodeId=4368189950644, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Dec 04 13:09:50 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418407, encodeId=0729141840edf, content=<a href='/topic/show?id=2cc91232947' target=_blank style='color:#2F92EE;'>#mTORC1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12329, encryptionId=2cc91232947, topicName=mTORC1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59413348493, createdName=雕雕, createdTime=Fri Jul 30 02:09:50 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2086150, encodeId=b88920861503d, content=<a href='/topic/show?id=82ed9548916' target=_blank style='color:#2F92EE;'>#酒精成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95489, encryptionId=82ed9548916, topicName=酒精成瘾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Wed Jun 08 22:09:50 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885334, encodeId=9c9c18853343b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 02 04:09:50 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088076, encodeId=d17320880e678, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Aug 05 09:09:50 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081430, encodeId=bf321081430cb, content=aws的情况确实要多关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Sat Dec 18 07:25:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899506, encodeId=4368189950644, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Dec 04 13:09:50 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418407, encodeId=0729141840edf, content=<a href='/topic/show?id=2cc91232947' target=_blank style='color:#2F92EE;'>#mTORC1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12329, encryptionId=2cc91232947, topicName=mTORC1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59413348493, createdName=雕雕, createdTime=Fri Jul 30 02:09:50 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-11-02 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=2086150, encodeId=b88920861503d, content=<a href='/topic/show?id=82ed9548916' target=_blank style='color:#2F92EE;'>#酒精成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95489, encryptionId=82ed9548916, topicName=酒精成瘾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Wed Jun 08 22:09:50 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885334, encodeId=9c9c18853343b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 02 04:09:50 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088076, encodeId=d17320880e678, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Aug 05 09:09:50 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081430, encodeId=bf321081430cb, content=aws的情况确实要多关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Sat Dec 18 07:25:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899506, encodeId=4368189950644, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Dec 04 13:09:50 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418407, encodeId=0729141840edf, content=<a href='/topic/show?id=2cc91232947' target=_blank style='color:#2F92EE;'>#mTORC1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12329, encryptionId=2cc91232947, topicName=mTORC1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59413348493, createdName=雕雕, createdTime=Fri Jul 30 02:09:50 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-08-05 liuli5079
  4. [GetPortalCommentsPageByObjectIdResponse(id=2086150, encodeId=b88920861503d, content=<a href='/topic/show?id=82ed9548916' target=_blank style='color:#2F92EE;'>#酒精成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95489, encryptionId=82ed9548916, topicName=酒精成瘾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Wed Jun 08 22:09:50 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885334, encodeId=9c9c18853343b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 02 04:09:50 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088076, encodeId=d17320880e678, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Aug 05 09:09:50 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081430, encodeId=bf321081430cb, content=aws的情况确实要多关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Sat Dec 18 07:25:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899506, encodeId=4368189950644, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Dec 04 13:09:50 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418407, encodeId=0729141840edf, content=<a href='/topic/show?id=2cc91232947' target=_blank style='color:#2F92EE;'>#mTORC1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12329, encryptionId=2cc91232947, topicName=mTORC1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59413348493, createdName=雕雕, createdTime=Fri Jul 30 02:09:50 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-12-18 carrotlyl

    aws的情况确实要多关注

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2086150, encodeId=b88920861503d, content=<a href='/topic/show?id=82ed9548916' target=_blank style='color:#2F92EE;'>#酒精成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95489, encryptionId=82ed9548916, topicName=酒精成瘾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Wed Jun 08 22:09:50 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885334, encodeId=9c9c18853343b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 02 04:09:50 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088076, encodeId=d17320880e678, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Aug 05 09:09:50 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081430, encodeId=bf321081430cb, content=aws的情况确实要多关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Sat Dec 18 07:25:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899506, encodeId=4368189950644, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Dec 04 13:09:50 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418407, encodeId=0729141840edf, content=<a href='/topic/show?id=2cc91232947' target=_blank style='color:#2F92EE;'>#mTORC1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12329, encryptionId=2cc91232947, topicName=mTORC1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59413348493, createdName=雕雕, createdTime=Fri Jul 30 02:09:50 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2086150, encodeId=b88920861503d, content=<a href='/topic/show?id=82ed9548916' target=_blank style='color:#2F92EE;'>#酒精成瘾#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95489, encryptionId=82ed9548916, topicName=酒精成瘾)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Wed Jun 08 22:09:50 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885334, encodeId=9c9c18853343b, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Nov 02 04:09:50 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088076, encodeId=d17320880e678, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Thu Aug 05 09:09:50 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081430, encodeId=bf321081430cb, content=aws的情况确实要多关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210127/50a003c4097845e182c08afd64d8a509/bd766dfebe9c40e0bca2dae964601bdc.jpg, createdBy=22de5454917, createdName=carrotlyl, createdTime=Sat Dec 18 07:25:46 CST 2021, time=2021-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1899506, encodeId=4368189950644, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Sat Dec 04 13:09:50 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418407, encodeId=0729141840edf, content=<a href='/topic/show?id=2cc91232947' target=_blank style='color:#2F92EE;'>#mTORC1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12329, encryptionId=2cc91232947, topicName=mTORC1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59413348493, createdName=雕雕, createdTime=Fri Jul 30 02:09:50 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-07-30 雕雕

相关资讯

JSAD:基因导致酒精成瘾者易饮食失调

一项刊登在《酒精与药物研究期刊》(Journalof Studies on Alcohol and Drugs)的研究报告指出,酒精成瘾症的患者,比较容易出现饮食失调问题,同样的,饮食失调患者,也较容易酒精成瘾,这可能与基因有关。 参与这项研究的圣路易华盛顿大学(Washington University in St. Louis)研究人员莫恩契尔诺夫(Melissa M

BMJ研究新闻:Meta分析发现纳美芬并不能有效地治疗酒精成瘾

据发表于PLoS Medicine的一项新的荟萃分析显示,当前的随机对照试验证据并不支持使用阿片受体拮抗剂纳美芬来治疗酒精成瘾,该荟萃分析中作者对一些监管部门批准纳美芬用于治疗酒精成瘾表示质疑。

Mol Psychiatr:复旦揭示酒精成瘾的表观遗传调控新机制

酒精使用障碍(Alcohol-use disorders, AUD)是一种慢性复发性脑疾病,其主要特征是强迫性饮酒、饮酒行为的控制能力受损以及对酒精的戒断反应。酒精依赖(Alcohol dependence)是AUD中的一种。酒精依赖的发生发展被认为是遗传因素和环境因素综合作用的结果。近年来开展了许多酒精滥用和酒精依赖相关的遗传学研究,筛选出了一系列酒精滥用和酒精依赖的易感基因。许多动物模型也被用